Keyphrases
Metastasis
100%
Pelvic Recurrence
100%
Preoperative Radiation
100%
Preoperative Chemotherapy
100%
Rectal Adenocarcinoma
100%
Positive Lymph Nodes
66%
Recurrence Rate
66%
Local Recurrence
66%
Disease-free Survival
66%
Residual Disease
66%
Sigmoidoscopy
66%
Concurrent Control
66%
Delayed Diagnosis
33%
Recurrent Disease
33%
Pathologic
33%
Computed Tomography
33%
Cisplatin
33%
Surgical Resection
33%
Female-to-male
33%
Major Complications
33%
Improved Survival
33%
Therapeutic Regimen
33%
Low Dose Rate
33%
Metastatic Disease
33%
Resection
33%
Distant Metastasis
33%
Median Survival
33%
Preoperative Chemoradiation
33%
Node-positive
33%
Current Therapies
33%
Kaplan-Meier
33%
Median Time
33%
Postoperative Morbidity
33%
Male-to-female Ratio
33%
Abdominoperineal Resection
33%
Before Surgery
33%
Biopsy-proven
33%
Optimal Treatment
33%
Local Control
33%
Rectal Carcinoma
33%
Fluorouracil
33%
Tumor Downstaging
33%
Histological Response
33%
Advanced Lesions
33%
Median Diameter
33%
Preoperative Chemoradiation Therapy
33%
Rectal Wall
33%
Less Radical Surgery
33%
Mantel
33%
Sphincter Preservation
33%
Tree Survival
33%
Rationing
33%
Microscopic Disease
33%
Complete Clinical Response
33%
Extrapelvic
33%
Medicine and Dentistry
Recurrent Disease
100%
Disease
100%
Metastatic Carcinoma
100%
Adenocarcinoma
100%
Preoperative Chemotherapy
100%
Preoperative Radiotherapy
100%
Pelvis
75%
Surgery
50%
Lymph Node
50%
Recurrence Risk
50%
Sigmoidoscopy
50%
Disease Free Survival
50%
Minimal Residual Disease
50%
Rectum Carcinoma
50%
Neoplasm
25%
Histopathology
25%
Sphincter
25%
Distant Metastasis
25%
Chemoradiotherapy
25%
Biopsy Technique
25%
Computer Assisted Tomography
25%
Abdominoperineal Resection
25%
Fluorouracil
25%
Cisplatin
25%
Chemoradiation Therapy
25%
Radical Surgery
25%